| CTRI Number |
CTRI/2024/10/075470 [Registered on: 17/10/2024] Trial Registered Prospectively |
| Last Modified On: |
16/10/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Dentistry |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Aged Garlic extract on minor RecurrentAphthous Stomatitis |
|
Scientific Title of Study
|
Comparative Evaluation of Aged Garlic extract and Triamcinolone Acetonide in minor Recurrent
Aphthous Stomatitis. A randomized controlled trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Rutuja Kadam |
| Designation |
PG Student |
| Affiliation |
Government Dental College And Hospital Nagpur |
| Address |
Room No. 22, Department of Oral Medicine and Radiology, Government Dental College and Hospital, Nagpur, Maharashtra 440003, India.
Nagpur MAHARASHTRA 440003 India |
| Phone |
9004733059 |
| Fax |
|
| Email |
dr.rutujakdam23@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DR.ASHITA KALASKAR |
| Designation |
Professor |
| Affiliation |
Government Dental College And Hospital Nagpur |
| Address |
Room No. 22, Department of Oral Medicine and Radiology, Government Dental College and Hospital, Nagpur, Maharashtra 440003, India.
Nagpur MAHARASHTRA 440003 India |
| Phone |
8550928585 |
| Fax |
|
| Email |
kalaskarashita@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
RUTUJA KADAM |
| Designation |
PG STUDENT |
| Affiliation |
Government Dental College And Hospital Nagpur |
| Address |
Room No. 22, Department of Oral Medicine and Radiology, Government Dental College and Hospital, Nagpur, Maharashtra 440003, India.
Nagpur MAHARASHTRA 440003 India |
| Phone |
9004733059 |
| Fax |
|
| Email |
dr.rutujakdam23@gmail.com |
|
|
Source of Monetary or Material Support
|
| Govt Dental College And Hospital,
Nagpur
Maharashtra
440003
India
|
|
|
Primary Sponsor
|
| Name |
DrRutuja Kadam |
| Address |
dept. of Oral medicine, radiology and diagnosis Government Dental
College & Hospital Nagpur, Govt. Medical Campus, Hanuman
Nagar, Nagpur MAHARASHTRA 440003 India
|
| Type of Sponsor |
Other [SELF] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Rutuja Kadam |
Government Dental College and Hospital Nagpur |
Room No 22,
Department Of Oral Medicine And Radiology,
Govt Dental College And Hospital,
Nagpur
Maharashtra
440003
India
Nagpur MAHARASHTRA |
9004733059
dr.rutujakadam23@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethical Committee Government Dental College Nagpur |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K120||Recurrent oral aphthae, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Aged Garlic Extract |
GROUP A
Four capsule each containing Aged garlic extract of 600mg.
Take two capsules with a meal two times a day. (BD)
(Total Dose-2,400mg,per day) For 2 weeks.
|
| Intervention |
combination therapy of Aged garlic extract capsule And triamcinolone acetonide 0.1 % buccal paste.
|
GROUP C
Take two capsules with a meal two times a day. (BD) (Total Dose-2,400mg,per day) For 2 weeks.
Triamcinolone acetonide 0.1 % buccal paste Apply three times a day on each ulcer after meals and not to consume food or water for half an hour after application For 2 weeks. |
| Comparator Agent |
Triamcinolone acetonide 0.1 % buccal paste |
GROUP B
Triamcinolone acetonide 0.1 % buccal paste
Apply three times a day on each ulcer after meals and not to consume food or water for half an hour after application For 2 weeks.
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Patients with minor recurrent aphthous stomatitis, Presenting with single or multiple minor aphthous ulcers of more than 48 hours duration,
Ulcers must be in locations easily accessible for evaluation and treatment, such as the buccal mucosa, labial mucosa, floor of
the mouth, or tongue.
Diagnosed with RAS according to the original
criteria of Lehner (1968). |
|
| ExclusionCriteria |
| Details |
History of allergies to garlic and triamcinolone acetonide,
Patients with recurrent aphthous ulcer major and recurrent herpetiform ulcer,
Patient already undergoing treatment for recurrent aphthous Stomatitis,
Pregnant and lactating females,
Patients on medication for any reason (oral problems, systemic Problems),
Patients with any systemic problem or syndrome,
Ulcers as a manifestation of systemic diseases. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
USS ulcerative severity score, (OHIS) Oral
health impact score |
Patient will be recalled at the end of 4 th day, 7 th day,14 th day
• Post treatment follow up will be done on
monthly basis for three months (30 th day, 60 th day, 90 th day)
• Evaluation of the following parameters
will be done on each visit
1.Ulcer Severity Score(USS)
2.Oral health impact score(OHIS)
3.Adverse effects if any
- If Recurrence occurs, standard treatment (Triamcinolone Acetonide
0.1% buccal paste) will be provided. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Side effects of intervention, if any |
Patient will be recalled at the end of 4th day, 7th
day,14th day.
Post treatment follow up will be done on monthly
basis for three months (30th day, 60th day, 90th
day).
Evaluation of the following parameters will be
done on each visit
1.Ulcer Severity Score(USS)
2.Oral health impact score(OHIS)
3.Adverse effects if any
- If Recurrence occurs, standard treatment
(Triamcinolone Acetonide 0.1% buccal paste)
will be provided |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
30/10/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study is randomized, parallel arm, open label clinical trial study considering the benefits of anti-inflammatory, anti-bacterial and immune modulatory properties of aged garlic extract, Aged garlic extract (AGE) capsules could be tried to evaluate its effect in Recurrent Aphthous Stomatitis(RAS). Also comparing it with first line therapy that is topical steroid would further help in exploring its effectiveness. Therefore this study is planned to evaluate the effectiveness of Aged garlic extract capsules in Recurrent Apthous stoamtatitis as compared to topical triamcenolone acetonide buccal paste (considered as the first line therapy in RAS) alone and dual therapy of AGE capsules and triamcenolone acetonide buccal paste. |